Article Text
Therapeutics
Adjunctive prandial or biphasic insulin for type 2 diabetes improved glycaemic control but increased hypoglycaemia and weight gain
Statistics from Altmetric.com
Footnotes
Source of funding: Novo Nordisk and Diabetes UK.
Footnotes
↵*Dr Waldron-Lynch was involved in recruitment and supervision of patients in the 4-T trial.